Differentiation of Alzheimer's, Huntington's, and Parkinson's Disease Patients on the Basis of Verbal Learning Characteristics

被引:49
|
作者
Kramer, Joel H. [1 ]
Levin, Bonnie E. [2 ]
Brandt, Jason [3 ]
Delis, Dean C. [4 ,5 ]
机构
[1] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA
[2] Univ Miami, Sch Med, Miami, FL USA
[3] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[4] VA Med Ctr, San Diego, CA USA
[5] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA
关键词
Cortical dementia; subcortical dementia; verbal learning; California; Verbal Learning Test; Alzheimer's disease; Parkinson's disease; Huntington's disease;
D O I
10.1037//0894-4105.3.2.111
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
This study examined the degree to which patients with dementia could be differentiated on the basis of their verbal learning characteristics. Patients with Parkinson's disease (PD), Huntington's disease (HD), and probable Alzheimer's disease (AD) were administered the California Verbal Learning Test. PD and HD patients were divided into subgroups to control for the severity of overall memory impairment. Discriminant function analysis correctly categorized over 76% of cases. Intrusions, perseverations, and rate of forgetting were the most discriminating variables. Profile differences between HD and PD were sufficiently robust to separate these two groups with reasonable accuracy. These results do not support a simplistic cortical-subcortical dichotomy; rather, individual dementing syndromes have unique patterns of verbal learning performance that are distinct from one another.
引用
收藏
页码:111 / 120
页数:10
相关论文
共 50 条
  • [41] Pilot study of computerized differentiation of Huntington's disease, schizophrenic, and Parkinson's disease patients using the contingent negative variation
    Jervis, B.W.
    Saatchi, M.R.
    Allen, E.M.
    Hudson, N.R.
    Oke, S.
    Grimsley, M.
    Medical and Biological Engineering and Computing, 1993, 31 (01): : 31 - 38
  • [42] Probabilistic category learning in patients with amnesia, Huntington's disease, or Parkinson's disease: The role of the hippocampus and basal ganglia
    Filoteo, JV
    Maddox, WT
    Davis, J
    JOURNAL OF COGNITIVE NEUROSCIENCE, 1998, 10 : 108 - 108
  • [43] Cytogenetic alterations in lymphocytes of Alzheimer's disease and Parkinson's disease patients
    Petrozzi, L
    Lucetti, C
    Scarpato, R
    Gambaccini, G
    Trippi, F
    Bernardini, S
    Del Dotto, P
    Migliore, L
    Bonuccelli, U
    NEUROLOGICAL SCIENCES, 2002, 23 (Suppl 2) : S97 - S98
  • [44] Analysis of visuospatial errors in patients with Alzheimer's disease or Parkinson's disease
    Finton, MJ
    Lucas, JA
    Graff-Radford, NR
    Uitti, RJ
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 1998, 20 (02) : 186 - 193
  • [45] Cytogenetic alterations in lymphocytes of Alzheimer's disease and Parkinson's disease patients
    L. Petrozzi
    C. Lucetti
    R. Scarpato
    G. Gambaccini
    F. Trippi
    S. Bernardini
    P. Del Dotto
    L. Migliore
    U. Bonuccelli
    Neurological Sciences, 2002, 23 : s97 - s98
  • [46] Biomonitoring of mycotoxins in the plasma of patients with Alzheimer's disease and Parkinson's disease
    Souques, Martine
    ENVIRONNEMENT RISQUES & SANTE, 2022, 21 (03): : 249 - 250
  • [47] Iron in Alzheimer's disease and Parkinson's disease
    Bush, A.
    JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 5 - 5
  • [48] Metallostasis in Alzheimer's disease and Parkinson's disease
    Bush, A., I
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2013, 51 : S27 - S27
  • [49] Biomarkers for Alzheimer's disease and Parkinson's disease
    Growdon, John H.
    Irizarry, Michael C.
    Scherzer, Clemens
    ADVANCES IN ALZHEIMER'S AND PARKINSON'S DISEASE: INSIGHTS, PROGRESS, AND PERSPECTIVES, 2008, 57 : 169 - 174
  • [50] α-Syrtuclein, Parkinson's disease, and Alzheimer's disease
    Kim, SH
    Seo, JH
    Suh, YH
    PARKINSONISM & RELATED DISORDERS, 2004, 10 : S9 - S13